Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2009 4
2010 1
2011 3
2012 7
2013 3
2014 3
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Results by year
Filters applied: . Clear all
Page 1
Cost-effectiveness of pharmacogenetics in anticoagulation: international differences in healthcare systems and costs.
Verhoef TI, Redekop WK, van Schie RM, Bayat S, Daly AK, Geitona M, Haschke-Becher E, Hughes DA, Kamali F, Levin LÅ, Manolopoulos VG, Pirmohamed M, Siebert U, Stingl JC, Wadelius M, de Boer A, Maitland-van der Zee AH; EU-PACT group. Verhoef TI, et al. Among authors: van schie rm. Pharmacogenomics. 2012 Sep;13(12):1405-17. doi: 10.2217/pgs.12.124. Pharmacogenomics. 2012. PMID: 22966889 Review.
Immunological risk of injectable drug delivery systems.
Jiskoot W, van Schie RM, Carstens MG, Schellekens H. Jiskoot W, et al. Among authors: van schie rm. Pharm Res. 2009 Jun;26(6):1303-14. doi: 10.1007/s11095-009-9855-9. Epub 2009 Feb 27. Pharm Res. 2009. PMID: 19247815 Review.
A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives.
Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA, Siebert U, de Boer A, Maitland-van der Zee AH, Barallon R, Briz M, Daly A, Haschke-Becher E, Kamali F, Kirchheiner J, Manolopoulos VG, Pirmohamed M, Rosendaal FR, van Schie RM, Wadelius M; EU-PACT Group. Verhoef TI, et al. Among authors: van schie rm. Pharmacogenomics. 2010 Jul;11(7):989-1002. doi: 10.2217/pgs.10.74. Pharmacogenomics. 2010. PMID: 20602617 Review.
Beliefs about medicines in Dutch acenocoumarol and phenprocoumon users.
Verhoef TI, Redekop WK, Bouvy ML, Dorenbos B, Karwar Z, van Schie RM, de Boer A, Maitland-van der Zee AH; EU-PACT group. Verhoef TI, et al. Among authors: van schie rm. Br J Clin Pharmacol. 2014 Aug;78(2):422-9. doi: 10.1111/bcp.12346. Br J Clin Pharmacol. 2014. PMID: 24528215 Free PMC article.
The effect of omeprazole and esomeprazole on the maintenance dose of phenprocoumon.
Verhoef TI, Zuurhout MJ, van Schie RM, Redekop WK, van der Meer FJ, le Cessie S, Schalekamp T, de Boer A, Maitland-van der Zee AH. Verhoef TI, et al. Among authors: van schie rm. Br J Clin Pharmacol. 2012 Dec;74(6):1068-9. doi: 10.1111/j.1365-2125.2012.04295.x. Br J Clin Pharmacol. 2012. PMID: 22497277 Free PMC article. No abstract available.
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon.
Verhoef TI, Ragia G, de Boer A, Barallon R, Kolovou G, Kolovou V, Konstantinides S, Le Cessie S, Maltezos E, van der Meer FJ, Redekop WK, Remkes M, Rosendaal FR, van Schie RM, Tavridou A, Tziakas D, Wadelius M, Manolopoulos VG, Maitland-van der Zee AH; EU-PACT Group. Verhoef TI, et al. Among authors: van schie rm. N Engl J Med. 2013 Dec 12;369(24):2304-12. doi: 10.1056/NEJMoa1311388. Epub 2013 Nov 19. N Engl J Med. 2013. PMID: 24251360 Free article. Clinical Trial.
Long-term anticoagulant effects of the CYP2C9 and VKORC1 genotypes in acenocoumarol users.
Verhoef TI, Redekop WK, Buikema MM, Schalekamp T, Van Der Meer FJ, Le Cessie S, Wessels JA, Van Schie RM, De Boer A, Teichert M, Visser LE, Maitland-Van Der Zee AH; EU-PACT Group. Verhoef TI, et al. Among authors: van schie rm. J Thromb Haemost. 2012 Apr;10(4):606-14. doi: 10.1111/j.1538-7836.2012.04633.x. J Thromb Haemost. 2012. PMID: 22252093 Free article.
21 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page